Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19.
作者信息
Avdeev Sergey, Moiseev Sergey, Brovko Michail, Yavorovskiy Andrey, Umbetova Karina, Akulkina Larisa, Tsareva Natalya, Merzhoeva Zamira, Gainitdinova Viliya, Fomin Victor
机构信息
Clinic of Pulmonology, Sechenov First Moscow State Medical University, Moscow, Russian Federation.
Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow, Russian Federation.
出版信息
Allergy. 2020 Oct;75(10):2703-2704. doi: 10.1111/all.14420. Epub 2020 Jun 12.
Abstract
摘要
相似文献
1
Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19.
Allergy. 2020 Oct;75(10):2703-2704. doi: 10.1111/all.14420. Epub 2020 Jun 12.
2
Asthma and COPD in Hospitalized COVID-19 Patients.
Arch Bronconeumol (Engl Ed). 2020 Sep;56(9):604-606. doi: 10.1016/j.arbres.2020.05.007. Epub 2020 May 31.
3
Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19.
J Allergy Clin Immunol. 2020 Oct;146(4):808-812. doi: 10.1016/j.jaci.2020.07.018. Epub 2020 Jul 29.
4
Prevalence of comorbid asthma in COVID-19 patients.
J Allergy Clin Immunol. 2020 Aug;146(2):334-335. doi: 10.1016/j.jaci.2020.04.061. Epub 2020 Jun 10.
5
Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19).
Respir Med. 2020 Jun;167:105941. doi: 10.1016/j.rmed.2020.105941. Epub 2020 Mar 24.
6
Use of corticosteroids in asthma and COPD patients with or without COVID-19.
Respir Med. 2020 Aug-Sep;170:106045. doi: 10.1016/j.rmed.2020.106045. Epub 2020 May 26.
7
[Asthma and COPD management during the COVID-19 pandemic].
Rev Med Suisse. 2020 May 6;16(692):933-938.
8
Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic.
J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2384-2385. doi: 10.1016/j.jaip.2020.04.053. Epub 2020 May 1.
9
Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.
Emerg Infect Dis. 2020 Aug;26(8):1679-1685. doi: 10.3201/eid2608.201776. Epub 2020 May 14.
10
Concerns About Coronavirus Disease-Related Collateral Damage for Patients With COPD.
Chest. 2020 Sep;158(3):866-868. doi: 10.1016/j.chest.2020.05.549. Epub 2020 May 28.
引用本文的文献
1
Impact of COVID-19 vaccination on cancer patients: safety, efficacy, and long-term effects.
Support Care Cancer. 2025 Aug 4;33(8):753. doi: 10.1007/s00520-025-09783-1.
2
Frequency of Stroke in Patients With Chronic Obstructive Pulmonary Disease: A Retrospective Study.
Cureus. 2025 Apr 26;17(4):e83054. doi: 10.7759/cureus.83054. eCollection 2025 Apr.
3
Bronchial Asthma and COVID-19: Etiology, Pathological Triggers, and Therapeutic Considerations.
Pathophysiology. 2024 May 27;31(2):269-287. doi: 10.3390/pathophysiology31020020.
4
Pre and post-COVID 19 infection pulmonary functions in children with chronic respiratory disease: A case series.
Respirol Case Rep. 2022 Dec 22;11(1):e01077. doi: 10.1002/rcr2.1077. eCollection 2023 Jan.
5
Inhaled corticosteroids for the treatment of COVID-19.
Eur Respir Rev. 2022 Nov 29;31(166). doi: 10.1183/16000617.0099-2022. Print 2022 Dec 31.
6
Comorbidity defines asthmatic patients' risk of COVID-19 hospitalization: A global perspective.
J Allergy Clin Immunol. 2023 Jan;151(1):110-117. doi: 10.1016/j.jaci.2022.09.039. Epub 2022 Nov 3.
7
A phenome-wide investigation of risk factors for severe COVID-19.
J Med Virol. 2023 Jan;95(1):e28264. doi: 10.1002/jmv.28264. Epub 2022 Nov 8.
8
COVID-19 and corticosteroids: a narrative review.
Inflammopharmacology. 2022 Aug;30(4):1189-1205. doi: 10.1007/s10787-022-00987-z. Epub 2022 May 13.
9
Causal Association and Shared Genetics Between Asthma and COVID-19.
Front Immunol. 2022 Mar 21;13:705379. doi: 10.3389/fimmu.2022.705379. eCollection 2022.
10
Asthma and the Risk of SARS-CoV-2 Infection Among Children and Adolescents.
Pediatrics. 2022 Jun 1;149(6). doi: 10.1542/peds.2021-056164.
本文引用的文献
1
Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19 - Georgia, March 2020.
MMWR Morb Mortal Wkly Rep. 2020 May 8;69(18):545-550. doi: 10.15585/mmwr.mm6918e1.
2
COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids.
Am J Respir Crit Care Med. 2020 Jul 1;202(1):83-90. doi: 10.1164/rccm.202003-0821OC.
3
Eosinophil responses during COVID-19 infections and coronavirus vaccination.
J Allergy Clin Immunol. 2020 Jul;146(1):1-7. doi: 10.1016/j.jaci.2020.04.021. Epub 2020 Apr 25.
4
Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2.
J Allergy Clin Immunol. 2020 Jul;146(1):203-206.e3. doi: 10.1016/j.jaci.2020.04.009. Epub 2020 Apr 22.
5
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. doi: 10.15585/mmwr.mm6915e3.
6
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.
J Allergy Clin Immunol. 2020 Jul;146(1):110-118. doi: 10.1016/j.jaci.2020.04.006. Epub 2020 Apr 12.
7
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis.
Aging (Albany NY). 2020 Apr 8;12(7):6049-6057. doi: 10.18632/aging.103000.
8
Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?
Lancet Respir Med. 2020 May;8(5):436-438. doi: 10.1016/S2213-2600(20)30167-3. Epub 2020 Apr 3.
9
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
10
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
Zotero 插件